Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy N Showalter

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Journal of Comparative Effectiveness Research|November 19, 2013
Oncology training programs: are we doing comparative effectiveness research justice?Nicholas G Zaorsky, Timothy N Showalter
Frontiers in Oncology|June 6, 2018
How Big Data, Comparative Effectiveness Research, and Rapid-Learning Health-Care Systems Can Transform Patient Care in Radiation OncologyJason C Sanders, Timothy N Showalter
Future Oncology (London, England)|September 8, 2015
Image-guided brachytherapy in cervical cancer: past, present and futureDaniel M Trifiletti, Timothy N Showalter
International Journal of Radiation Oncology, Biology, Physics|August 21, 2012
In regard to Yeoh et alNitin Ohri, Robert Den, Timothy N Showalter
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized TrialsKosj Yamoah, Timothy N Showalter, Nitin Ohri
Cancer Biology & Therapy|February 14, 2014
Strategic evaluation of interventions to prevent consequential late proctitis after prostate radiation therapy: new clinical trial designs should be consideredTimothy N Showalter, Nolan A Wages, Nitin Ohri
The Canadian Journal of Urology|August 16, 2012
Late toxicity rates following definitive radiotherapy for prostate cancerNitin Ohri, Adam P Dicker, Timothy N Showalter
International Journal of Radiation Oncology, Biology, Physics|June 21, 2011
In reply to Dr. King (Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?)Nitin Ohri, Adam P Dicker, Timothy N Showalter
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
What Is Reasonably Foreseeable? Lessons Learned From the SUPPORT TrialDaniel M Trifiletti, Timothy N Showalter, Lois Shepherd
Future Oncology (London, England)|November 22, 2016
Failing to deliver established quality treatment for cervical cancer: what is going on and how can we improve it?Colin Hill, Daniel M Trifiletti, Timothy N Showalter
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Journal of Comparative Effectiveness Research|November 19, 2013
Oncology training programs: are we doing comparative effectiveness research justice?Nicholas G Zaorsky, Timothy N Showalter
Frontiers in Oncology|June 6, 2018
How Big Data, Comparative Effectiveness Research, and Rapid-Learning Health-Care Systems Can Transform Patient Care in Radiation OncologyJason C Sanders, Timothy N Showalter
Future Oncology (London, England)|September 8, 2015
Image-guided brachytherapy in cervical cancer: past, present and futureDaniel M Trifiletti, Timothy N Showalter
International Journal of Radiation Oncology, Biology, Physics|August 21, 2012
In regard to Yeoh et alNitin Ohri, Robert Den, Timothy N Showalter
International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized TrialsKosj Yamoah, Timothy N Showalter, Nitin Ohri
Cancer Biology & Therapy|February 14, 2014
Strategic evaluation of interventions to prevent consequential late proctitis after prostate radiation therapy: new clinical trial designs should be consideredTimothy N Showalter, Nolan A Wages, Nitin Ohri
The Canadian Journal of Urology|August 16, 2012
Late toxicity rates following definitive radiotherapy for prostate cancerNitin Ohri, Adam P Dicker, Timothy N Showalter
International Journal of Radiation Oncology, Biology, Physics|June 21, 2011
In reply to Dr. King (Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?)Nitin Ohri, Adam P Dicker, Timothy N Showalter
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
What Is Reasonably Foreseeable? Lessons Learned From the SUPPORT TrialDaniel M Trifiletti, Timothy N Showalter, Lois Shepherd
Future Oncology (London, England)|November 22, 2016
Failing to deliver established quality treatment for cervical cancer: what is going on and how can we improve it?Colin Hill, Daniel M Trifiletti, Timothy N Showalter
Pageof 19